Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
46
CORT Quote, Financials, Valuation and Earnings
Last price:
$68.59
Seasonality move
:
2.94%
Day range:
$65.07 - $68.87
52-week range:
$20.84 - $117.33
Dividend yield:
0%
P/E ratio:
55.34x
P/S ratio:
11.54x
P/B ratio:
10.65x
Volume:
1.1M
Avg. volume:
2M
1-year change:
188.08%
Market cap:
$7.2B
Revenue:
$675M
EPS (TTM):
$1.24
Corcept Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
CORT
Corcept Therapeutics
|
05/01/2024 | 10-Q | 10-Q filing on 05/01/2024 | View Form |
|
CORT
Corcept Therapeutics
|
11/01/2023 | 10-Q | 10-Q filing on 11/01/2023 | View Form |
|
CORT
Corcept Therapeutics
|
08/02/2023 | 10-Q | 10-Q filing on 08/02/2023 | View Form |
|
CORT
Corcept Therapeutics
|
05/03/2023 | 10-Q | 10-Q filing on 05/03/2023 | View Form |
|
CORT
Corcept Therapeutics
|
11/03/2022 | 10-Q | 10-Q filing on 11/03/2022 | View Form |
|
CORT
Corcept Therapeutics
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
CORT
Corcept Therapeutics
|
05/05/2022 | 10-Q | 10-Q filing on 05/05/2022 | View Form |
|
CORT
Corcept Therapeutics
|
11/03/2021 | 10-Q | 10-Q filing on 11/03/2021 | View Form |
|
CORT
Corcept Therapeutics
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
CORT
Corcept Therapeutics
|
05/06/2021 | 10-Q | 10-Q filing on 05/06/2021 | View Form |
|
CORT
Corcept Therapeutics
|
11/03/2020 | 10-Q | 10-Q filing on 11/03/2020 | View Form |
|
CORT
Corcept Therapeutics
|
08/04/2020 | 10-Q | 10-Q filing on 08/04/2020 | View Form |
|
CORT
Corcept Therapeutics
|
05/04/2020 | 10-Q | 10-Q filing on 05/04/2020 | View Form |
|
CORT
Corcept Therapeutics
|
02/24/2020 | 10-K | 10-K filing on 02/24/2020 | View Form |
|
CORT
Corcept Therapeutics
|
11/07/2019 | 10-Q | 10-Q filing on 11/07/2019 | View Form |
|
CORT
Corcept Therapeutics
|
08/01/2019 | 10-Q | 10-Q filing on 08/01/2019 | View Form |
|
CORT
Corcept Therapeutics
|
05/09/2019 | 10-Q | 10-Q filing on 05/09/2019 | View Form |
|
CORT
Corcept Therapeutics
|
02/26/2019 | 10-K | 10-K filing on 02/26/2019 | View Form |
|
CORT
Corcept Therapeutics
|
11/02/2018 | 10-Q | 10-Q filing on 11/02/2018 | View Form |
|
CORT
Corcept Therapeutics
|
08/09/2018 | 10-Q | 10-Q filing on 08/09/2018 | View Form |
|
CORT
Corcept Therapeutics
|
05/09/2018 | 10-Q | 10-Q filing on 05/09/2018 | View Form |
|
CORT
Corcept Therapeutics
|
02/28/2018 | 10-K | 10-K filing on 02/28/2018 | View Form |
|
CORT
Corcept Therapeutics
|
11/03/2017 | 10-Q | 10-Q filing on 11/03/2017 | View Form |
|
CORT
Corcept Therapeutics
|
08/02/2017 | 10-Q | 10-Q filing on 08/02/2017 | View Form |
|
CORT
Corcept Therapeutics
|
05/02/2017 | 10-Q | 10-Q filing on 05/02/2017 | View Form |
|
CORT
Corcept Therapeutics
|
03/06/2017 | 10-K | 10-K filing on 03/06/2017 | View Form |
|
CORT
Corcept Therapeutics
|
11/02/2016 | 10-Q | 10-Q filing on 11/02/2016 | View Form |
|
CORT
Corcept Therapeutics
|
08/03/2016 | 10-Q | 10-Q filing on 08/03/2016 | View Form |
|
CORT
Corcept Therapeutics
|
05/04/2016 | 10-Q | 10-Q filing on 05/04/2016 | View Form |
|
CORT
Corcept Therapeutics
|
03/10/2016 | 10-K | 10-K filing on 03/10/2016 | View Form |
|
CORT
Corcept Therapeutics
|
11/06/2015 | 10-Q | 10-Q filing on 11/06/2015 | View Form |
|
CORT
Corcept Therapeutics
|
08/07/2015 | 10-Q | 10-Q filing on 08/07/2015 | View Form |
|
CORT
Corcept Therapeutics
|
05/08/2015 | 10-Q | 10-Q filing on 05/08/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
